Suppr超能文献

危重症儿童短期乙酰氨基酚用药错误后肝酶变化:一项队列研究。

Liver enzymes after short-term acetaminophen error in critically ill children: a cohort study.

机构信息

Department of Critical Care Medicine, The Hospital for Sick Children, Toronto, ON, Canada.

Child Health Evaluative Sciences, and Center for Safety Research, SickKids Research Institute, Toronto, ON, USA.

出版信息

Eur J Pediatr. 2022 Aug;181(8):2943-2951. doi: 10.1007/s00431-022-04502-y. Epub 2022 May 18.

Abstract

UNLABELLED

Drug-associated harm is common but difficult to detect in the hospital setting. In critically ill children, we sought to evaluate drug-associated hepatic injury following enteral acetaminophen error, defined as acetaminophen dosing that exceeds daily maximum recommendations. This retrospective cohort study took place in two pediatric intensive care units within a pediatric hospital center. The included patients are children (< 18 years of age) admitted to the pediatric and cardiac intensive care unit between January 2008 and January 2018, and receiving enteral acetaminophen. We defined acetaminophen dosing error as exceeding daily acetaminophen dosing by > 10% the upper limit of maximum recommended dose for weight and age (> 82.5 mg/kg/day or > 4400 mg/day). We included 14,146 admissions, who received 147,485 doses of acetaminophen. Acetaminophen dosing errors occurred 1 in every 9.5 patient-days on acetaminophen. ALT and AST decreased significantly over the course of ICU admission (p < 0.0001). In patients with acetaminophen errors, ALT and AST measured in the 24 to 96 h post error were not significantly different than when measured outside this window. A sensitivity analysis using > 100 mg/kg/day as the upper daily acetaminophen error cut-off did not reveal any subsequent significant increase in ALT or ALT in the 24 to 96-h post-error window, compared to measurements taken outside the window.

CONCLUSION

Although the administration of acetaminophen in critically ill children frequently exceeds the daily recommended limit and vigilance is needed, we did not find any associated increase in liver transaminases following acetaminophen errors.

WHAT IS KNOWN

• Acetaminophen dosing errors are common in pediatric outpatients. • Excessive acetaminophen dosing can be associated with harm, including hepatic injury.

WHAT IS NEW

• Exceeding daily acetaminophen dosing limit occurs 1 in every 9.5 patient-days in children admitted to the critical care unit. • In patients with daily dose excess of acetaminophen, we did not find a significant increase in the measured liver enzymes in the 24 to 96 h following the overdosing.

摘要

未加标签

药物相关的危害在医院环境中很常见,但很难发现。在危重症儿童中,我们试图评估肠内给予对乙酰氨基酚(acetaminophen)导致的药物相关肝损伤,定义为剂量超过每日最大推荐剂量。本回顾性队列研究在一家儿童医院的两个儿科重症监护病房进行。纳入的患者为 2008 年 1 月至 2018 年 1 月期间收入儿科和心脏重症监护病房的年龄<18 岁的儿童,给予肠内给予对乙酰氨基酚。我们将对乙酰氨基酚剂量错误定义为剂量超过每日最大推荐剂量(根据体重和年龄计算,超过上限的>10%,即>82.5mg/kg/天或>4400mg/天)。共纳入 14146 例住院患者,共接受 147485 次对乙酰氨基酚治疗。在使用对乙酰氨基酚的患者中,每 9.5 个患者日就会发生 1 次剂量错误。ALT 和 AST 在 ICU 住院期间显著降低(p<0.0001)。在发生对乙酰氨基酚剂量错误的患者中,在错误发生后 24 至 96 小时内测量的 ALT 和 AST 与不在此时间窗内测量的 ALT 和 AST 无显著差异。使用>100mg/kg/天作为每日最大对乙酰氨基酚错误的上限进行敏感性分析,与不在该时间窗内测量相比,在错误发生后 24 至 96 小时内并未发现 ALT 或 AST 有任何显著增加。

结论

尽管在危重症儿童中给予对乙酰氨基酚的频率经常超过每日推荐剂量,但我们并未发现乙酰氨基酚剂量错误后肝转氨酶有任何升高。

已知

•在儿科门诊患者中,对乙酰氨基酚的剂量错误很常见。•过量的对乙酰氨基酚给药可能会造成危害,包括肝损伤。

新内容

•在入住重症监护病房的儿童中,每 9.5 个患者日就会发生 1 次超过每日对乙酰氨基酚剂量限制的情况。•在每日剂量超过对乙酰氨基酚的患者中,我们未发现过量后 24 至 96 小时内测量的肝酶显著增加。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验